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Abstract
Changes in homeostatic function, including sleep patterns and energy balance, are often
predictive of age-related neurocognitive disorders such as Alzheimer’s and Parkinson’s
disease. The basal forebrain has been implicated in both attentional processing and
responses to homeostatic cues, suggesting a possible link between the significantly
impaired attention task performance of Alzheimer’s and Parkinson’s patients and shifts
in their homeostatic regulation. Recent research suggests a possible mechanism: the
basal forebrain receives input from hypothalamic neurons that release the excitatory
neuropeptides, orexin-A and orexin-B (orexins). Orexins bind with varying affinities to
orexin-1- and orexin-2-receptors on cholinergic neurons in the basal forebrain and
increase the rate at which they fire action potentials in response to attentional demands
and regulation of homeostasis. Degeneration of these cholinergic projections to the
cortex is a hallmark of Alzheimer’s and Parkinson’s, but it is currently unknown if
impairment is due solely to loss of these projections, or if the decline can be attributed
to loss of particular receptors on these neurons. In order to evaluate the necessity of
orexin-2-receptors for attentional performance, TCS-OX2-29, an orexin-2-receptor
selective, non-peptide antagonist was administered via bilateral infusion into the basal
forebrain of Rattus norvegicus prior to completion of an attention task with a distracter
present. The findings suggest a dose- and block-dependent decline in correct rejections
at the 40 nm TCS-OX2-29 infusion into the basal forebrain on the sustained attention
task with distracter compared to saline administration. An exploratory analysis
technique revealed possible improvements in relative hits at 2 nm and 20 nm
TCS-OX2-29 infusions into the basal forebrain. Combined, these findings suggest that
the orexin-2-receptor is involved in attentional performance, and that blocking the
orexin-2-receptor with TCS-OX2-29 may, at high doses, result in a decline in correct
rejections, while lower doses of 2 nm and 20 nm may be involved in sensitization of the
orexin-2-receptor, making it more likely to respond to binding of orexin A and orexin B.
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Introduction
Changes in homeostatic function, including sleep patterns and energy balance,
may be predictive of age-related neurocognitive disorders such as Alzheimer’s and
Parkinson’s disease (Fadel & Burk, 2010). The basal forebrain has been implicated in
both attentional processing and responses to homeostatic cues, suggesting a possible
link between the significantly impaired attention task performance of Alzheimer’s and
Parkinson’s patients and shifts in their homeostatic regulation (Fadel & Burk, 2010).
Recent research suggests a possible mechanism: the basal forebrain receives input
from hypothalamic neurons that release the excitatory neuropeptides (orexins), which
bind with varying affinities to orexin-1- and orexin-2-receptors on cholinergic neurons in
the basal forebrain. The binding of orexins to orexin-1- and orexin-2-receptors results in
an increase the rate at which these cholinergic neurons fire action potentials in response
to attentional demands and regulation of homeostasis (Fadel, Jolivalt, & Reagan, 2013).
Degeneration of these cholinergic projections into the basal forebrain is a hallmark of
both Alzheimer’s disease (Auld, Kornecook, Bastianetto, & Quirion, 2002) and
Parkinson’s disease (Bohnen & Albin, 2011).
As humans age, neurons with receptors for orexins become sparser, limiting
behavioral responses to homeostatic cues because there are fewer neurons that respond
to orexins. The overall sensitivity of neurons to orexins is thus weakened. The link
between shifts in homeostatic functions and the onset of aging related
neurodegenerative disorders gives rise to the hypothesis that orexins and the cholinergic
neurons they bind to in the basal forebrain cholinergic system (BFCS) may be involved
in the onset of the characteristic attentional impairment observed in Alzheimer’s disease
(Fadel & Burk, 2010). However, it is currently unknown if this impairment is due solely
to loss of these hypothalamic projections to the basal forebrain, or if the decline can be
attributed to loss of particular excitatory receptors on these neurons.
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Purpose
The purpose of this study was to examine the role of basal forebrain
orexin-2-receptors in attentional performance. This role was examined by administering
TCS-OX2-29, an orexin-2-receptor selective antagonist, bilaterally into the basal
forebrain, and measuring subject performance on a sustained attention task with
distracter (Zajo, Fadel, & Burk, 2015), used to measure attentional performance in rats.
The experimental hypothesis stated that if the dose of TCS-OX2-29 infused directly
into the basal forebrain was increased, then attentional performance on the sustained
attention task with distracter would decrease. Analysis of data was conducted using
traditional ANOVA testing of each dose × trial block and dose × signal duration on
performance measure. Additionally, models are described in the Results that measure
the effects of repeated distracter exposure and repeated infusion into the basal
forebrain, using sham and distracter-only trials. An exploratory analysis was conducted
to determine if there was a difference between performance measures on experimental
trials compared to performance at corresponding (distracter, infusion) points. These
points represent expected performance, had the subject received a saline infusion or
distracter-only trial, rather than a TCS-OX2-29 dose trial, at the given (distracter,
infusion) point. Paired t-tests were then used to compare predicted (curve-generated)
values with experimental values. This additional analysis allowed for some control over
the possible learning curve that may accompany distracter exposure, and the possible
exponential decay in performance that may accompany the physical damage caused by
repeated infusions into the basal forebrain.
Basal Forebrain Cholinergic System (BFCS)
The basal forebrain encompasses the septum, diagonal band nuclei, and substantia
innominata (Ramachandran, Gupta, & Tranel, 2012). Notably, the basal forebrain has
been implicated in attention, motivation, memory, and aging-related neurodegenerative
diseases including Alzheimer’s and Parkinson’s (Blanco-Centurion, Gerashchenko, &
Shiromani, 2007).
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The cholinergic system refers to projections leaving the basal forebrain that
release the neurotransmitter, acetylcholine, in the hippocampus and cerebral cortex
(Ramachandran et al., 2012). Unlike the acetylcholine mechanism at the neuromuscular
junction, which initiates muscle contraction by opening ligand-gated sodium channels in
the central nervous system, here acetylcholine acts primarily through metabotropic
means at G protein-coupled receptors (Picciotto, Higley, & Mineur, 2012).
A study conducted by Henny and Jones (2008) of the rat basal forebrain showed
that of the neuronal terminals projecting from the basal forebrain into the prefrontal
cortex, about 19 percent are cholinergic. Miettinen, Kalesnykas, and Koivisto (2002)
estimated that there were 26390± 1097 cholinergic neurons in the rat basal forebrain.
Within the diagonal band of Broca (a part of the basal forebrain), Miettinen et al.
(2002) reported 9647± 504 cholinergic neurons. Likewise, the horizontal band of Broca
housed 9403± 484 cholinergic neurons, and the nucleus basalis encompassed 7312± 281
cholinergic neurons (Miettinen et al., 2002). Communication between the basal
forebrain and lateral hypothalamus is bidirectional; many orexin neurons within the
hypothalamus are known to synapse onto cholinergic and non-cholinergic neurons in the
basal forebrain (Zaborszky, Cullinan, & Braun, 1991).
Cholinergic neurons do not maintain distinct connections when compared to
nearby non-cholinergic neurons (Grove, 1988). Because these clusters of cholinergic
neurons are widespread throughout the basal forebrain, the BFCS may play an
important role in coordinating interactions between specialized cortical and subcortical
networks. This could account for why the BFCS is implicated in the development of
both cortical and subcortical attentional networks (Parikh & Sarter, 2008). In other
words, the basal forebrain cholinergic system could be involved in the development of
both cortical (i.e., Alzheimer’s) and subcortical dementias (i.e., motor symptoms of
Parkinson’s).
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Orexinergic System
The orexinergic system is comprised of two orexin neuropeptides, orexin A (OxA)
and orexin B (OxB), and two receptors, known as orexin-1-receptor (OX1R) and
orexin-2-receptor (OX2R) (Sakurai et al., 1998).
Originally, orexins were considered modulators of hunger cues and sleep/wake
cycles, but since the initial discovery of the orexin system by Sakurai et al. in 1998,
components of the system have been implicated in several homeostatic processes.
Scientists noted dramatic reductions in functional orexin-1- and orexin-2-receptors in
canine narcolepsy, suggesting orexin system involvement in sleep patterns (Lin et al.,
1999). As previously discussed, changes in sleep patterns may be an early sign of
neurodegenerative disorders. Further, orexin-producing cells are responsive to leptin
and ghrelin (Ramachandran et al., 2012), which help modulate food intake through
activating satiety and hunger responses, respectively. Hunger, too, is a homeostatic cue
that also may be affected by early degeneration in neurodegenerative disorders (Fadel &
Burk, 2010). Additionally, orexins may be involved in maintenance of attentional
processes. Wheeler et al. (2014) showed that loss of orexin neurons disrupts acquisition
of conditioned orienting responses. Boschen, Fadel, and Burk (2009) showed that both
systemic injection and direct infusion into the basal forebrain of SB-33467, an
orexin-1-antagonist, impairs attentional performance. These relationships suggest a
strong link between homeostatic changes that precede the impaired attentional
performance notable in Alzheimer’s and Parkinson’s patients, and implicates the
degeneration of the orexinergic system as a possible mechanism for the aging-related
decline.
Peptides. Both OxA and OxB are produced by a small population of neurons
in the hypothalamus, and derived from prepro-orexin via proteolytic cleavage (Sakurai
et al., 1998). These two neuropeptides share about 64 percent sequence homology, but
differ significantly in binding affinity for OX1R and OX2R (Sakurai et al., 1998). OxA
binds with approximately equal affinities to both receptors, however OxB binds with
10-fold higher affinity to OX2R than to OX1R (Sakurai et al., 1998).
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Receptors. Both OX1R and OX2R are G-protein coupled receptors (Sakurai et
al., 1998). Their implication in learning, memory and attention is based on the widely
accepted premise that highly selective changes in the strength of synaptic connections
between neurons in the brain contribute to learning and memory. There are two main
mechanisms by which both OX1R and OX2R may be involved in long term changes at
the synaptic terminal and post-synaptic membrane, and a third mechanism by which
only OX2R may be involved. The first two mechanisms involve the coupling of Gq/11 to
OX1R and OX2R upon binding of OxA or OxB to either receptor. The Gq/11 effector,
phospholipase C, goes on to hydrolyze PIP2, a phospholipid found in the plasma
membrane, forming second messengers IP3 and diacylglycerol. Diaglycerol attaches
protein kinase C to the plasma membrane, while IP3 binds to the IP3 receptor on the
cytoplasmic side of the endoplasmic reticulum. The IP3 receptor opens as a
calcium-selective ion channel, and calcium rushes out of the endoplasmic reticulum.
This calcium binds to and activates protein kinase C at the neuronal membrane
(Newton, 1995).
The first mechanism is dependent upon this activation of protein kinase C.
Protein kinase C is known to be involved in the maintenance and persistence of long
term potentiation, which is integral to learning plasticity (Routtenberg, 1986).
Activation of protein kinase C has been implicated in the persistence, or delayed decay,
of a response to a stimulus (Routtenberg, 1986).
However, the impacts of intracellular calcium are not limited to the protein kinase
C pathway. The second mechanism involves the increased intracellular calcium that
results from the binding of IP3 to the IP3 receptor during the aforementioned cascade.
Calcium has been heavily implicated in learning plasticity. In particular, there is strong
evidence for calcium involvement in generation of long term potentiation, or the
selective strengthening of synapses after they have been strongly activated before.
When intracellular calcium concentration increases, calmodulin-dependent kinase II in
the dendritic spines can be activated (Herring & Nicoll, 2016). Calmodulin-dependent
kinase II can then go on to phosphorylate AMPA receptors, which increases
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conductance of AMPA channels (Herring & Nicoll, 2016). Ehlers (2000) also showed
that calmodulin-dependent kinase II can induce the incorporation of additional AMPA
receptors into the post-synaptic membrane. Both of these changes serve to strengthen a
synapse following strong activation (Herring & Nicoll, 2016).
The third mechanism is specific to OX2R, which can couple to Gs or Gi (Tang et
al., 2008) and then triggers a cyclic AMP (cAMP) signalling cascade. In the case of Gs
the alpha subunit binds to adenylyl cyclase, activating it. Activated adenylyl cyclase
goes on to catalyze the conversion of ATP to cAMP. Increases in intracellular
concentration of cAMP can result in activation of protein kinase A, which
phosphorylates AMPA and transcription factors that can regulate gene expression.
Changes in AMPA receptor expression and gene expression of other proteins can
influence long-term potentiation (Herring & Nicoll, 2016).
OX2R and OX1R differ in their distribution within the brain. Trivedi, Yu,
Macneil, Ploeg, and Guan (1998) analyzed mRNA expression of OX1R and OX2R in
the rat brain. They noted that OX1R mRNA expression is highest in the ventromedial
hypothalamic nucleus, tenia tecta, hippocampal formation, dorsal raphe, and locus
coeruleus (Trivedi et al., 1998). In contrast, OX2R mRNA expression is highest in the
paraventricular nucleus, cerebral cortex, nucleus accumbens, subthalamic and
paraventricular thalamic nuclei, and the anterior pretectal nucleus (Trivedi et al., 1998).
Staining for these receptors showed that both receptors populate the hypothalamus,
and that OX1R is also localized to the locus coeruleus, while OX2R is present
throughout the cortex (Mould, Brown, Marshall, & Langmead, 2013). These differences
in distribution suggest that these receptors may have distinct roles in the modulation of
homeostatic functions (Ebrahim, Howard, Kopelman, Sharief, & Williams, 2002).
OX1R and OX2R also have varying affinities for ligands OxA and OxB. OX1R
binds with 100 to 1000-fold higher affinity to OxA than to OxB (Ebrahim et al., 2002).
OX2R is less selective, and binds to both OxA and OxB with approximately equal
affinity (Ebrahim et al., 2002).
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Orexin-2-receptor antagonist: TCS-OX2-29
TCS-OX2-29 (Tocris) is an OX2R-selective non-peptide antagonist. Supplier data
states that TCS-OX2-29 exhibits 250-fold selectivity for the OX2R compared to OX1R
and other ion channels and transporters. TCS-OX2-29 has a molecular weight of 433.97
grams per mole, and chemical formula: C23H31N3O3 ·HCl. This antagonist is soluble
up to 25mm in dimethyl sulfoxide (DMSO). All solutions used in this study were
diluted in DMSO to concentrations lower than 25mm.
Several OX1R and OX2R antagonists have been developed, although specificity,
half lives, and IC50 values vary. A study conducted by Mould et al. (2013) involved
competition kinetics analyses of several well-known OX2R antagonists including
almorexant, suvorexant, SB-408124, SB-334867, EMPA, and TCS-OX2-29. This study
showed that TCS-OX2-29 has both the highest dissociation rate (koff = 0.22 /min) and
that TCS-OX2-29 has the shortest dissociation half-life of the compounds analyzed.
Additionally, TCS-OX2-29 has the largest Ki of the compounds tested, and therefore
the lowest binding affinity to OX2R compared to the other antagonists. The IC50 of
TCS-OX2-20 in 40 nm. Taken together, these attributes suggest that TCS-OX2-29 is
highly selective for OX2R, but compared to other antagonists, TCS-OX2-29 binds to
OX2R only transiently.
Materials and Methods
Subjects
Seven male Fischer Brown Norway F1 hybrid rats were used (Charles River
Laboratories, Wilmington, MA). All rats were housed in pairs during training, and
switched to individual housing following surgery in order to prevent interference with
the implanted guide cannulae by a cagemate. The vivarium where the rats were housed
throughout the study was temperature and humidity controlled and operated on a 14:10
hour light/dark cycle (lights on 0600). In order to minimize omissions by subjects on
training and sustained attention tasks (for which water was used as a reward for correct
responses), all rats were water restricted throughout the experiment. Subjects received
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water during daily training or testing sessions and for 10 minutes after each session.
The latency of water access following a session ranged from 15-30 minutes after
completion of the session. This varied delay in water access was incorporated to
discourage omissions during sessions. Rats were trained five to seven days a week, and
received at least 20 minutes of water access on days when no behavioral testing
occurred. Food was provided ad libitum throughout the experiment. Training
procedures, surgical implantation, and sustained attention task administration closely
followed methods used by Zajo et al. (2015) and Kozikowski and Burk (2016).
Animals were treated and handled in accordance with the guidelines of the
Animal Care and Use Committee at The College of William and Mary.
Testing Chambers
Rats were trained and tested in individual chambers, each of which was mounted
within a sound attenuating box (Med Associates, Inc.). Further information regarding
illumination levels within these chambers has been documented (Burk, 2004).
One wall of each chamber had a water port positioned with a dipper that could
hold a volume of 10 µL. This dipper was controlled externally through the MED-PC IV
software, and programmed to provide water rewards of 10 µL for each correct response
during a session.
Subject responses were recorded in the form of lever presses. Each chamber had
one retractable lever on either side of the water port (two total levers per chamber).
Above the water port and each lever was a single panel light, for a total of three panel
lights. These lights were used as stimuli; illumination was programmed within the
MED-PC IV software. A house light was positioned on the opposite side of each
chamber and was off during sessions unless otherwise specified in a particular task.
At the start of daily testing, all the boxes were tested to ensure proper panel light,
house light, lever and dipper function.
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Attentional Performance Tasks
Training Task. Subjects were initially trained on a shaping task to learn to
press an extended lever for a water reward. The task employed an FR-1 schedule of
reinforcement. In order to prevent subjects from favoring one of the two levers over the
other, if one lever was pressed more than five consecutive times, the subject would not
be rewarded until the other lever was pressed. Subjects continued testing on this task
until they received 120 or more rewards of a possible 162 rewards for three consecutive
sessions.
Following successful shaping, subjects began training to distinguish between two
trial types: signal trials, which included a single second illumination of the middle panel
light, and nonsignal trials, in which there was no illumination of the middle panel light.
In order to respond to the signal stimulus, rats were trained to press one of the two
levers. Half the subjects, randomly selected, were rewarded with three seconds of access
to 10 µL for pressing the right side lever in response to a signal trial. The other half of
the subjects were rewarded with three seconds of access to 10µL for pressing the left
side lever in response to a signal trial, and for pressing the right side lever in responses
to a nonsignal trial. For the other half of the subjects, the rats were rewarded for
pressing the right side lever in response to a signal trial, and for pressing the left side
lever in response to a nonsignal trial. Animals were cued to respond by the extension of
both response levers after each signal or nonsignal. There was a twelve second pause
between trials.
During this training period, attempts were made to modify incorrect responses
using correction trials (repeats of the incorrect trial). If, following an incorrect response,
a subject responded incorrectly to three consecutive correction trials, a forced correction
trial was initiated, in which only the correct lever was extended for 90 seconds for the
rat to press in response to the signal or nonsignal.
After rats performed this task with greater than 70 percent relative hits in
response to the 500-ms signal, and greater than 70% correction rejections for a minimum
of three consecutive days, they were switched to the Sustained Attention Task.
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Sustained Attention Task. The purpose of the Sustained Attention Task was
to create a more attentionally demanding environment by requiring subjects to
differentiate between 5-ms, 100-ms, and 500-ms signals (illumination of the central
panel light). Additionally, the time between trials was varied between six and twelve
seconds to further increase attentional demands. As during training sessions, for
animals that were trained to press the right side lever in response to a 1-ms
illumination, a right lever press was documented as a ’hit’ for 5-ms, 100-ms, and 500-ms
signal trials, and a left lever press was documented as a ’correct rejection’ on nonsignal
trials. If an animal in this group pressed the left lever in response to a signal trial, this
response was documented as a ’miss.’ If an animal in this group pressed the right side
lever in response to a nonsignal trial, this response was documented as a ’false alarm.’
Finally, if an animal in this group did not press either lever in response to a signal or
nonsignal trial, this was recorded as an ’omission.’ These rules were reversed for the rats
originally trained to press the left side lever in response to a signal trial.
Trials were divided into three blocks of 54 trials each. There were 27 signal and 27
nonsignal trials per block, and each signal duration (500-ms, 100-ms, and 25-ms) was
presented a total of 27 times throughout the entire testing session. Trials were selected
randomly without replacement.
Once subjects had again reached greater than 70% relative hits in response to the
500-ms signal, and greater than 70% correct rejections for a minimum of three
consecutive days, they were surgically implanted with guide cannulae bilaterally into
the basal forebrain. Following a minimum seven-day recovery period after surgery, rats
continued testing on the Sustained Attention Task until they reached pre-surgical
accuracy in hits in response to 500-ms signals and correct rejections.
Sustained Attention Task with Distracter. This task was identical to the
Sustained Attention Task, however during the second trial block (trials 55 through 109)
the houselight flashed on and off (2 second period) repeatedly throughout the block.
The flashing house light serves to produce a cognitively demanding condition that is
thought to disrupt attentional performance in several neuropsychiatric conditions
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(Sarter, Hasselmo, Bruno, & Givens, 2005). The Sustained Attention Task with
Distracter was used for all experimental trials during which data was recorded for
analysis, but in between data collection days, which occurred at a maximum rate of one
data collection day every other day, rats completed the Sustained Attention Task
(without distracter).
Surgical Procedure
At least 12 hours prior to surgery, rats received 2.6 mg/mL acetaminophen in
their drinking water. The following morning, rats received 90 mg/kg ketamine
combined with 9.0 mg/kg xylazine for anesthesia. In order to ensure that subjects were
sufficiently anesthetized, the withdrawal reflex of the back paws was checked. Once the
response was negative, the surgical area was shaved, and subjects were positioned in a
stereotaxic apparatus. All surgical procedures were conducted under aseptic conditions.
All subjects were received implants of 8-mm, 22 guage guide cannulae bilaterally into
the basal forebrain (−1.3mm anterior-posterior (AP) and +2.7mm medial-lateral (ML)
from bregma and −4.2mm from dura). Following implantation of the guide cannulae,
three stainless steel screws were secured in the skull and the surgical area around the
screws and cannulae was filled with dental cement. Subjects were given a minimum of
one week to recover following surgical implantation of guide cannulae bilaterally into
the basal forebrain. During the recovery period, animals had free access to water and
food available ad libitum. Following this recovery period, subjects were returned to the
water-restricted schedule and continued on the Sustained Attention Task training until
their performance was comparable to pre-surgical performance (greater than 0.7 rH500
and 0.7 rCR) for at least three consecutive days.
Infusion Procedure
Infusions were made through the insertion of an internal cannula (28 gauge) that
extended 3mm beyond the guide cannula, attached to a Hamilton syringe by
polyethylene tubing. For each infusion, the right hemisphere was infused prior to the
left hemisphere. The internal cannula was left in place for one minute following the
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completion of each infusion to allow for drug diffusion (Zajo et al., 2015). Bilateral
infusions of 0.5 µL saline (control) or 0.5 µL of 2 nm, 20 nm, or 40 nm TCS-OX2-29,
diluted in DMSO, were administered to subjects at a rate of 0.5 µL/min immediately
before beginning the Sustained Attention Task with Distracter. While not in use,
TCS-OX2-29 solutions, which were aliquoted into single-use vials, were kept frozen at
4◦C. Solutions were thawed immediately prior to use. Subjects were tested on Sustained
Attention Task with Distracter sessions immediately following infusion.
These trials were conducted with at least one non-infusion, non-distracter day
between trials to allow subjects to return to baseline performance between experimental
trials. Dose order was randomized in order to minimize ordering effects. Each subject
received a minimum of one sham infusion with distracter trial. Four subjects also
completed distracter only (with no infusion) trials at the before the first infusion session
and following the final infusion session. Sham and distracter only sessions were used to
model potential effects of distracter adaptation and infusion-induced brain damage on
attentional task performance. Subject 5502 was used as a surgical control. This rat
received surgery to implant guide cannulae bilaterally into the basal forebrain, but did
not receive any infusions, and therefore data from this subject is not included in
statistical analysis of dose-dependent performance. The table below shows the in which
each subject completed experimental trials. "Sham" denotes a saline infusion, and
"distr." denotes that the subject performed the experimental task (Sustained Attention
Task with Distracter) without any infusion.
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Table 1. Trials for each subject in the order conducted.
Subject Trial 1 2 3 4 5 6 7
5501 distr. 20 40 40 sham 2 -
5502 distr. distr. distr. distr. distr. distr. distr.
5701 distr. 40 2 sham 20 distr. 2
5702 20 2 40 sham 20 - -
5803 sham 2 40 - - - -
6001 sham 40 20 2 sham - -
6011 distr. 2 sham 20 40 distr. -
Performance Measures
Subject responses to each trial were recorded within the MED-PC IV software.
Data were converted using MEDPC2XL into spreadsheet format for analysis. Once
uploaded to Google Sheets, a macro (Appendix) was scripted and applied within the
Google Sheets platform to calculate the relevant measures. These measures included:
the number of hits (H500, H100, or H25, corresponding to number of hits on 500-ms,
100-ms, and 25-ms signal trials, respectively), misses (M500, M100, M25, corresponding
to misses on 500-ms, 100-ms, and 25-ms signal trials, respectively), correct rejections
(CR), false alarms (FA) and omissions. These measures were used to calculate fraction
hits and ultimately, a Sustained Attention Test score (SAT) for each block of trials. All
unscripted measures are described, with abbreviations, in Table 2.
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Table 2. Performance measures, abbreviations, and formula for calculation for each
measure examined by statistical analysis.
Measure Abbreviation Formula
Fraction Hits at 500-ms rH500 H500/(H500 +M500)
Fraction Hits at 100-ms rH100 H100/(H100 +M100)
Fraction Hits at 25-ms rH25 H25/(H25 +M25)
Fraction Hits Overall rHO (1/3)× (rH500 + rH100 + rH25)
Fraction Correct Rejections rCR CR/(CR + FA)
Fraction Correct Rejections for Block y rCRy CRy/(CRy + FAy)
Fraction Hits for Block y rHOy Using only Block y trials:
(1/3)× (rH500 + rH100 + rH25)
Fraction Hits at x Signal rHx if x = 500, rHx = rH500
if x = 100, rHx = rH100
if x = 25, rHx = rH25
if x = O, rHx = rHO
Sustained Attention Test Overall SAT SAT = ((rHO − FA)/
(2× (rHO + FA)− (rHO + FA)2)
Sustained Attention Test at y Block SATBy SATBy = ((rHOy − FA)/
(2× (rHOy + FA)− (rHOy + FA)2)
Results
Analysis using repeated measures, three-factor (dose, signal duration and block
number) repeated measures ANOVA showed a significant effect of block on SATBy
(α = 0.05 , df = 2, F = 5.057, p = 0.038), as well as a significant effect of signal
duration on SAT score at each signal duration (df = 2, F = 5.057, p < 0.001).
Additionally, there was a significant effect of block × dose on SAT score
(df = 6, F = 6.242, p < 0.001). In order to isolate effects of block × dose on rHO and
rCR, both components of the SAT score were analyzed. A repeated measures
one-factor ANOVA showed that the effect of dose on rHOy was not significant during
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Block 1 (F = 1.548, p = 0.253), Block 2 (F = 0.533, p = 0.668), or Block 3
(F = 2.279, p = 0.132). Similarly, a repeated measures one-factor ANOVA showed that
the effect of dose on rCRy was not significant during Block 1
(df = 3, F = 1.328, p = 0.311) or Block 2 (df = 3, F = 1.026, p = 0.416). The effect
of dose on rCR3 was significant for Block 3 (df = 3, F = 4.010, p = 0.034). Taken
together, these data suggest that for Blocks 1 and 2, both changes in rHOy and rCRy
contribute to the significance of the block × dose effect on SAT. In Block 3, the
significance of the effect of dose on rCR3 suggests that changes in block × dose
dependent changes in correct rejections contribute more to the change in SAT than does
rHO3.
Figure 1. The effect of TCS-OX2-29 dose on overall SAT score.
Although the SAT score is a useful, well characterized (McGaughy & Sarter, 1998)
statistic for analyzing behavioral data on a sustained attention task, the formula for the
score does not include an omissions factor. Thus, a subject can correctly respond to as
little as a single cue, and then omit all additional trials, and have the same SAT score
as an animal that responds correctly to each of the 162 trials. The dataset of
experimental sessions did include trials with non-eligible omissions at all dose levels. A
repeated measures ANOVA analyzing dose × block showed that there was not a
significant block-dependent increase in omissions (df = 18, F = 3.715, p = 0.072) nor
OREXIN-2-RECEPTORS IN THE BASAL FOREBRAIN 20
was there a significant effect of dose × block on number of omissions
(df = 18, F = 2.359, p = 0.062). Both effects are approaching significance at α = 0.05.
An increase in omissions in later blocks is an expected effect observed in sustained
attention task data in rats (McGaughy & Sarter, 1998), possibly due to decreases in
motivation following each additional reward.
Omissions data is particularly relevant in the context of the orexinergic system,
because orexins are involved in regulating sleep/wake cycles as well as feeding behavior
(Ramachandran et al., 2012). In this study, sleep cycles and feeding behavior were not
monitored. However, in the sustained attention tasks, shifts in the sleep/wake resulting
in fatigued subjects, and a decreased thirst drive resulting from changes in feeding
behavior could contribute to increased omissions in experimental trials. Because there
was no significant difference in number of omissions between saline trials and
TCS-OX2-29 trials, the omissions data suggest that there was not a significant increase
in fatigue or significant decrease in thirst contributing to behavioral performance on the
sustained attention task with distracter.
Baseline Performance Analysis (Block 1 vs. Block 2)
Baseline performance on the Sustained Attention Task was established for each
experimental trial, using the values from Block 1. Comparing Block 2 values on
rH500, rH100, rH25, rHO, rHy, and SAT to those for Block 1 allowed control over
day-to-day variation in subject performance on the task. Because ANOVA showed no
significant difference in hits from a dose × signal duration
(df = 2, F = 1.702, p = 0.164), all additional analyses used rHO and rHOy.
Because Block 2 included a distracter, while Block 1 did not, analysis was
conducted to examine dose-dependent differences between these two blocks.
Accordingly, differences were computed for (rHO1− rHO2) and (rCR1− rCR2). A
positive value from either of these difference computations would indicate that the
subject performed better in Block 2 with distracter present than in Block 1 without
distracter present. A repeated measures ANOVA showed no significant dose effect on
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(rHO1− rHO2) values α = 0.05 (df = 3, F = 3.049, p = 0.061).
Figure 2. The effect of TCS-OX2-29 dose on rHO1 - rHO2. A positive value indicates
that relative hits decreased from Block 1 to Block 2, while a negative value indicates
that relative hits increased from Block 1 to Block 2.
Distracter Adaptation and Infusion-Induced Brain Damage
The flashing house light serves to produce a cognitively demanding condition that
is thought to disrupt attentional performance in several neuropsychiatric conditions
(Sarter et al., 2005). The improvement in performance as subjects are repeatedly
exposed to the distracter during the sustained attention task has been examined by
Kozikowski and Burk (2016). Results showed that subjects performed significantly
worse than baseline during the first exposure to the distracter, and that this effect was
not statistically significant after the first exposure to the distracter (Kozikowski &
Burk, 2016). However, in the study by Kozikowski and Burk (2016), the flashing
houselight distracter was present throughout the testing session, rather than during a
single block. We intentionally limited distracter exposure to a single block in order to
minimize distracter-related learning. Still, controlling for these repeated exposures to
distracter should serve to normalize the data. Additionally, the physical damage that
results from repeatedly inserting the internal cannulae to deliver TCS-OX2-29 could
OREXIN-2-RECEPTORS IN THE BASAL FOREBRAIN 22
cause damage to neurons in the infusion region of the basal forebrain, which may
decrease scores on performance measures including rHxy, rCRy, and SAT .
Combined, these effects may pose confounds to performance data from infusion
trials. A subject may improve in performance with a distracter present from the first
trial to the second trial according to a sigmoidal learning curve. Simultaneously,
repeated infusions may further impair the performance of a subject on the distracter
task according to an exponential decay function, independently of the effects of
TCS-OX2-29.
In order to evaluate the significance of these effects and isolate this influence on
the dataset, data from subjects receiving saline infusions on their second, third, fourth,
fifth, sixth and seventh exposures to distracter were compiled. After performing T-tests
to compare the rHx, rCR, and omissions values for subjects performing the distracter
task but receiving no infusion compared to subjects performing the distracter task after
receiving a saline infusion, and finding no significant difference between saline trials and
distracter-only trials, data from distracter-only trials were also incorporated into the
model.
Fitting a Sigmoidal × Exponential Surface. The learning curve is
predicted to be sigmoidal, while the effects of repeated infusions are predicted to follow
an exponential decay curve. Therefore, a sigmoidal × exponential surface fit is
appropriate. The general model, (A ∗ exp(B ∗ i)) ∗ (C/(1 + exp(−D ∗ d))) was fit to the
data. The variables ’d’ and ’i’ correspond to the number of distracter exposures and the
number of infusions, respectively. The vertical axis lists the variable being plotted.
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Figure 3. The effect of distracter exposure and repeated infusions on rHO1.
Coefficients (with 95% confidence bounds):
A = -0.826 (-5.531e+07, 5.531e+07)
B = -0.1052 (-0.2635, 0.05316)
C = -0.9769 (-6.542e+07, 6.542e+07)
D = 0.2134 (-0.6467, 1.074)
Goodness of fit:
SSE: 1.038
R-square: 0.143
Adjusted R-square: -0.01764
RMSE: 0.2547
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Figure 4. The effect of distracter exposure and repeated infusions on rHO2.
Coefficients (with 95% confidence bounds):
A = 0.7785 (-4.775e+07, 4.775e+07)
B = -0.1941 (-0.3974, 0.009121)
C = 1.012 (-6.21e+07, 6.21e+07)
D = 0.2326 (-0.7209, 1.186)
Goodness of fit:
SSE: 1.02
R-square: 0.2352
Adjusted R-square: 0.09175
RMSE: 0.2524
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Figure 5. The effect of distracter exposure and repeated infusions on rHO3.
Coefficients (with 95% confidence bounds):
A = 0.4169 (-8.652e+07, 8.652e+07)
B = -0.2336 (-0.8265, 0.3594)
C = 0.414 (-8.593e+07, 8.593e+07)
D = 0.3882 (-6.055, 6.831)
Goodness of fit:
SSE: 0.43
R-square: 0.09938
Adjusted R-square: -0.06949
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RMSE: 0.1639
Fitting an Interpolated Cubic Spline Surface. Given the R-square and
adjusted R-square scores listed for Figures 3 through 5, the generated surfaces are poor
fits for the data presented. It is general practice to fit according to the expected
functions, rather than arbitrarily increasing polynomial degree to achieve the highest
possible R-square or adjusted R-square, because doing so would increase the probability
of Type I error. Theoretically, repeated exposures to distracter should result in a
learning curve as the animals get used to the distracter, and repeated infusions should
result in an exponential decay curve as the first infusion should cause more damage
than the next, which should cause more damage than the next, and so on. However, the
relationship may be more complex. It is possible that neuronal plasticity is allowing
synapses to circumvent the infusion area, more quickly in some subjects than others. It
is also possible that given the known homeostatic components influenced by the
orexinergic system (for example sleep and feeding behavior), subject motivation and
sleep/wake cycles may be fluctuating and affecting the rHOy data, in ways that cannot
be predicted by a general sigmoidal × exponential model.
The purpose of developing this distracter × infusion surface model is to be able to
predict what the performance of a subject would have been, had the animal received
saline rather than TCS-OX2-29 during any given experimental trial. For this reason, a
better fit than what was possible with the sigmoidal × exponential model on the
current dataset is necessary. Rather than arbitrarily assigning a higher order
polynomial fit to the data, an interpolated fit has been selected to present a second
model. Although the following figures present models with better goodness of fit values
than the previously presented models, they do not attempt to assert any direct
relationship between the variables. Rather, an interpolated surface was applied to
establish a smooth gradation connecting each point.
According to Liu (n.d.), there are two relevant methods of interpolation: linear
interpolation and cubic interpolation. A linear interpolation is useful for points related
by a linear relationship, but for points close together, a linear spline interpolation cannot
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capture the curvature of a function (Liu, n.d.). The first derivative of the function are
discontinuous at the measured nodes (Liu, n.d.). This discontinuity at measured nodes
may result in interpolated values near measured nodes that are more different (as a
linear fit has been applied) than the predicted values would be in reality (Liu, n.d.).
The goal of cubic spline interpolation, on the other hand, is to obtain an
interpolation formula that is continuous in both the first and second derivatives, both
within the intervals and at the interpolating nodes, ultimately resulting in a smoother
interpolating function (Liu, n.d.). For the context of distracter × infusion relative hits
and omissions, a smooth function was preferred, therefore cubic spline interpolation was
selected. Statistical analysis using both the sigmoidal × exponential fit and the cubic
spline interpolation fit is included.
Figure 6. The effect of distracter exposure and repeated infusions on rHO1, with a
piecewise, interpolated fit.
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Goodness of fit:
SSE: 0.659
R-square: 0.456
Figure 7. The effect of distracter exposure and repeated infusions on rHO2, with a
piecewise, interpolated fit.
Goodness of fit:
SSE: 0.3928
R-square: 0.7054
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Figure 8. The effect of distracter exposure and repeated infusions on rHO3, with a
piecewise, interpolated fit.
Goodness of fit:
SSE: 0.05093
R-square: 0.8933
Both the sigmoidal × exponential fit and the interpolated fit were used to
separately approximate ’predicted’ values on rHOy for each (distracters, infusions)
point. These predictors were intended to represent the values rHOy values that
subjects would have received if, rather than an experimental trial, they had received a
saline trial in its place. For example, subject 5701 received a 2 nm infusion of
TCS-OX2-29 as the third exposure to distracter and second infusion. Based on the
sigmoidal × exponential fit data, this suggests that had the subject received a saline
trial as the third exposure to distracter and second infusion,
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predicted rHO1 = 0.4277861404, rHO2 = 0.2619720761, rHO3 = 0.02571390485.
Based on the interpolated fit, if the subject had received a saline trial as the third
exposure to distracter and second infusion,
predicted rHO1 = 0.425, rHO2 = 0.2292, rHO3 = 0.00129. The performance of
subject 5702 with the 2 nm TCS-OX2-29 infusion was actually
rHO1 = 0.74, rHO2 = 0.45, rHO3 = 0.22.
Figure 9. The effect of dose on rHO1, with comparison of the sigmoidal × exponential
prediction and the interpolated cubic spline prediction.
Figure 10. The effect of dose on rHO2, with comparison of the sigmoidal × exponential
prediction and the interpolated cubic spline prediction.
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Figure 11. The effect of dose on rHO3, with comparison of the sigmoidal × exponential
prediction and the interpolated cubic spline prediction.
After completing predictions for all subjects corresponding to (distracter, infusion)
values for each trial the subjects completed, a series of paired T-tests were completed
comparing the experimental values to predicted values from both the sigmoidal ×
exponential and the interpolated fits. Notably, Figures 9 through 11 suggest that many
of the experimental values of rHOy were significantly higher than the predicted values
from both models. Analysis using paired T-tests, comparing actual values to predicted
values with both models, showed that there was a significant difference in Block 2
between the interpolated rHO2 and actual rHO2 for the 20 nm dose (p = 0.033) and
40 nm dose (p = 0.008). These differences could not be computed using the sigmoidal ×
exponential fit for the 20 nm dose and the 40 nm dose because the standard error of the
difference was 0. In Block 3, there was a significant difference between the interpolated
rHO3 and actual rHO3 at the 0 nm dose (p = 0.025), at the 2 nm dose (p = 0.018), at
the 20 nm dose (p = 0.035), but not at the 40 nm dose (p = 0.080). Using the sigmoidal
× exponential fit, there was a significant difference between the predicted rHO3 and
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actual rHO3 at the 0 nm dose (p = 0.025), 2 nm dose (p = 0.017), and at the 20 nm dose
(p = 0.027) as well. Again, there was no significant difference at the 40 nm dose
(p = 0.076). In contrast to the traditional analysis using repeated measures ANOVA at
the beginning of the Results section, which showed no significant dose dependent
difference in relative hits at each block, all of the significant differences determined by
these paired T-tests indicated dose dependent improvement with TCS-OX2-29 on the
relative hits measure, compared to the predicted relative hits if saline had been infused.
However, these contrasting results do not necessarily imply that either analysis
technique is inaccurate. The relative hits measure, like the SAT score, can be artificially
high in trials with significant omissions. If there is a dose-dependent effect of
TCS-OX2-29 on the number of omissions, and if the number of omissions increases at
higher doses of TCS-OX2-29, then it is possible that subjects are responding to fewer
trials and therefore the relative hits values analyzed above are not truly representative
of performance.
In order to evaluate this hypothesis, interpolant cubic spline fits were applied to
omissions data from the model dataset, which was composed of only saline infusion and
distracter only trials. A sigmoidal × exponential fit was not applied, because the
number of omissions may not be related to a learning curve or damage to the brain
region directly. Fatigue and changes in motivation due to administration of
TCS-OX2-29, rather, may be responsible for the primary effect. The fits applied in
Figures 12 through 14 all suggest a trend toward increased omissions with increased
exposure to distracter and increased infusions.
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Figure 12. The effect of repeated distracter exposure and repeated infusions on
omissions in Block 1, using an interpolated cubic spline fit.
Goodness of fit:
SSE: 2421
R-square: 0.4487
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Figure 13. The effect of repeated distracter exposure and repeated infusions on
omissions in Block 2, using an interpolated cubic spline fit.
Goodness of fit:
SSE: 2611
R-square: 0.4696
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Figure 14. The effect of repeated distracter exposure and repeated infusions on
omissions in Block 3, using an interpolated cubic spline fit.
Goodness of fit:
SSE: 2605
R-square: 0.6436
These interpolations were used to predict the estimated number of omissions
expected, if subjects had received a saline infusion in place of the corresponding
TCS-OX2-29 experimental trial. The following figures show the predicted omissions
compared to actual omissions.
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Figure 15. Comparison of Interpolated Cubic Spline predicted omissions in Block 1,
compared to measured omissions.
Figure 16. Comparison of Interpolated Cubic Spline predicted omissions in Block 2,
compared to measured omissions.
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Figure 17. Comparison of Interpolated Cubic Spline predicted omissions in Block 3 ,
compared to measured omissions.
Follow up analysis using paired T-tests showed that there was a significant
difference in the predicted number of omissions and actual number of omissions in
Blocks 2 and 3 at the 20 nm dose. At this dose, there were fewer than the predicted
number of omissions. There was no significant difference in predicted number of
omissions compared to actual omissions at the 0 nm (saline), 2 nm, and 40 nm doses
Blocks 1, 2 or 3.
Discussion
Traditional Analysis
This study examined whether antagonism of OX2R bilaterally in the basal
forebrain using TCS-OX2-29 could inhibit attentional performance via direct infusions
into the basal forebrain. Analyses were conducted with traditional ANOVA testing for
sustained attention task data, implemented previously by Kozikowski and Burk (2016)
and Zajo et al. (2015). The results described suggest that there is a significant decline
in the SAT score measure of performance dependent on TCS-OX2-29 dose and block
number. Further analyses suggested trends that this effect was due both to the relative
hits during each block and to the relative correct rejections at each block, however, the
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dose × block effect was not significant on relative hits for any blocks, and was only
significant during Block 3 for relative correct rejections. Baseline performance analysis
showed that there was no significant effect of TCS-OX2-29 dose on subject performance
differences between Block 1 and Block 2. Notably, several dose effects were approaching
significance, including the block dependent increase in omissions (F = 3.715, p = 0.072),
dose × block effect on number of omissions (F = 2.359, p = 0.062) and the dose effect
on the baseline adjusted Block 2 relative hits (F = 3.049, p = 0.061).
The results of this well-documented method of analysis suggest that combined,
block number and dose of TCS-OX2-29 may have an effect on SAT score performance
by affecting both the fraction of hits on a task and the fraction of correct rejections.
Additional trials to increase the power and sample size of the analysis are necessary to
elucidate the effects of dose on number of omissions, dose × block on number of
omissions, and dose on the relative hits in Block 2, adjusted for baseline performance
from Block 1. The trend toward a dose × block dependent increase in omissions, while
not significant, may suggest that the subjects experience a speed-accuracy tradeoff. Due
to the antagonism of TCS-OX2-29 receptors in the basal forebrain, the neurons with
orexin-2-receptors likely respond less frequently to local orexins A and B. Subjects may
respond more slowly to stimuli and thus be scored with higher ’omissions,’ while
maintaining similar relative hits values compared to their saline trials.
Exploratory Analysis
As described previously, an exploratory analysis was performed using models of
the effect of repeated distracter exposures and repeated infusions on overall relative hits
and omissions during each block. Two models, a sigmoidal × exponential fit and an
interpolated cubic spline fit, were developed for the relative hits during each block, to
allow for interpolation of relative hits during each block at combinations of distracter
exposures and repeated infusions under sham infusion and distracter-only conditions.
When analyzed in comparison to the predicted relative hits values, there was no
significant improvement or decline in performance during Block 1, the well-trained
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version of the task that corresponded to the sustained attention task without distracter
that the subjects practiced daily. However, when compared with predicted performance
using a sigmoidal × exponential and an interpolated model, subjects had higher relative
hits values in Block 2, the more attention-demanding task, at 20 nm and 40 nm doses of
TCS-OX2-29. Accordingly, TCS-OX2-29 does not appear to significantly impact
relative hits in the first block, but may have an impact when attentional demands
increase. An analogous conclusion was presented by Zajo et al. (2015), in a study that
administered orexin A to improve attention performance. Improvement was significant
only in Block 2, when attentional demands were increased using a flashing distracter.
In the final block, there was a dose dependent significant difference in correct
rejections, and when both prediction models were used, there was also a significant
difference in relative hits with the sham infusion, 2 nm, and 20 nm infusions. The
number of omissions dependent on dose × block was approaching significance when
analyzed using traditional ANOVA testing, and it is possible that increased omissions in
Block 3 were artificially contributing to higher variation in relative hits scores, because
a subject that responds to only a few trials can easily achieve a significantly higher
relative hits value than a subject that responds to all the trials. Interpolated predictions
of the expected number of omissions using saline and distracter-only trials suggested
that at the 20 nm dose in both Blocks 2 and 3, subjects omitted significantly fewer trials
than were predicted by the model. At other doses and in other blocks, there was no
significant difference between the interpolated number of omissions compared to actual
omissions.
Because there was no significant increase in omissions using this analysis method,
the resultant findings using this exploratory analysis differ from the findings of the
traditional analysis. According to this exploratory analysis, in both Blocks 2 and 3,
subjects that received 20 nm TCS-OX2-29 infusions had decreased omissions compared
to the interpolated number of omissions, and increased relative hits compared to the
predicted fraction of relative hits using both the interpolated and sigmoidal ×
exponential models. At all other doses of TCS-OX2-29, there was no significant
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difference in omissions. Thus, according to this exploratory analysis, subjects had
increased values of relative hits during Block 2 with 20 nm and 40 nm infusions, with
decreases and no changes in relative hits, respectively. In block 3, subjects had
increased values of relative hits with 0 nm, 2 nm and 20 nm doses of TCS-OX2-29, with
either no significant difference in, or decreases in, the number of omissions compared to
the predicted omissions values.
This improvement on both relative hits and omissions measures is in contrast to
the original hypothesis, that higher doses of TCS-OX2-29 infusion into the basal
forebrain bilaterally would disrupt attention by antagonizing orexin-2-receptors, and
does not support the speed-accuracy tradeoff explanation provided. Notably, allosteric
sensitization of nicotinic receptors at following interaction with a subgroup of
cholinesterase inhibitors, known as allosterically potentiating ligands(Maelicke et al.,
2001). Following interaction at the nicotinic receptor, receptor sensitization occurs,
which means that interaction of the receptor with the ligand, acetylcholine, is more
likely to induce channel opening (Maelicke et al., 2001). Similarly, the interaction at
orexin-2-receptors of TCS-OX2-29, with a relatively high dissociation rate of
koff = 0.22/min) and relatively short dissociation half life, may actually result in
sensitization of the orexin-2-receptor, making it mo re likely to respond to binding of
orexins A and B. Because the dissociation rate is high and the dissociation half life is
short, the brief binding of TCS-OX2-29 at the orexin-2-receptor may serve to improve
performance, by increase activity of these neurons rather than inhibiting activity.
Limitations
Because infusions must be carried out by physically inserting a cannula into the
basal forebrain, brain damage following surgery and brain damage resulting from
repeated infusions is inevitable. We attempted to minimize the damage by placing the
guide cannula 3-mm above the target site. Additionally, placement of the guide
cannulae can only be established based on typical location of the basal forebrain in the
average rat (using relative distances from bregma and dura). Thus, cannula placement
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cannot be confirmed until after completing experimental sessions. Further, there exists
subject-to-subject variation in the number of OX2Rs in the basal forebrain, as
evidenced by the ranges of OX2R receptors in the rat basal forebrain documented by
Miettinen et al. (2002). Performance on the sustained attention task with distracter
may also be affected by the amount of previous experience with distracter. A study
conducted by Kozikowski and Burk (2016), in which a distracter was presented
throughout the entire testing session, the effect of distracter exposure is only significant
for the first experience with distracter. In this experiment, distracter exposure occurred
only during Block 2 of the testing session. This was done explicitly to minimize the
effect of distracter-related learning on the SAT scores, relative hits, and correct
rejections. However, the trends depicted in Figures 3 through 8 do suggest that relative
hits trended toward higher values with additional distracter exposures and fewer
infusions. Finally, established methods of analysis measuring SAT score, relative hits,
and relative correct rejections do not account for omissions, and thus a score on any of
these measures can be artificially high if a subject correctly responds to a few stimuli
and omits all additional trials.
Further Study
Additional research should, most importantly, include additional test subjects in
order to increase power and sample size and minimize the probability that any
differences between dose are due to chance. Increased sample size will simultaneously
provide additional data to construct more robust sigmoidal × exponential and
interpolated models of the combined effects of distracter exposure and repeated
infusions bilaterally into the basal forebrain. Additionally, latency analysis should be
conducted to determine if subjects were responding more slowly to stimuli in an
TCS-OX2-29 dose-dependent manner. Histological analysis should be completed and
guide cannula placement should be confirmed for each subject, to ensure that infusions
of TCS-OX2-29 were administered to corresponding locations in each subject.
Patch clamp analyses of the orexin-2-receptor in the presence of TCS-OX2-29,
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conducted according to the methodology described by Maelicke et al. (2001) would be
beneficial to establish stronger understanding of the effect of TCS-OX2-29 on the
orexin-2-receptor. An experiment using patch clamp could be used to determine if
TCS-OX2-29, at doses corresponding to the 2 nm and 20 nm doses described in this
study may potentiate the orexin-2-receptor. Additionally, such an experiment could
provide valuable information regarding dose-dependent effects of TCS-OX2-29 on the
orexin-2-receptor.
Finally, analysis measures should be developed and documented to account for
omission rates in an overall performance score. One approach would involve analyzing
total hits and correct rejections rather than calculating relative hits and relative correct
rejections. However, this method would require hits, misses, correct rejections, false
alarms, and omissions to all be analyzed separately, as none of these measures include
information about any other measures, unlike the relative values (for example, relative
hits contains information about the number of hits and the number of misses). Thus, it
would be more difficult to account for interplay between these factors.
Alternatively, a composite score similar to the SAT score could be developed with
an omissions factor included. However, considerations in developing such a score would
need to include appropriately weighting the omissions factor. That is, if the entire SAT
score were multiplied by (1− omissions)/total stimuli, a subject that completed a
single correct hit and omitted the rest of the trials during Block 1 would have the same
SAT score as a subject that performed pressed the ’no signal’ lever in response to 26 of
the 27 nonsignal trials. Also, adding an omissions factor would introduce the omissions
error into the measure. Therefore, the definition of a new measure would need to be
carefully assigned prior to using the score for analysis.
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Appendix
The code listed below is compatible with Google Scripts for bulk data analysis on
Training and Sustained Attention Task (with and without distracter) sessions using
MEDPC2XL output with the ”attentiontask.mtp” settings file implemented. The code
can output overall values for rH500, rH100, rH25, rCR, FA, and Omissions. Slight
modifications to the provided code also allow the user to generate block-wise data.
function dayRpt ( ) {
var s , data , i , rw=[ ] , j , sum=[ ] , t e s t , k , rpt ;
s=SpreadsheetApp . getAct iveSpreadsheet ( ) . getSheetByName ( "Raw" ) ;
data=s . getDataRange ( ) . getValues ( ) ;
for ( i in data ) { i f ( data [ i ] [0 ]== ’ Subject ’ ) rw . push (Number( i ) )
; }
rw . push ( data . l ength ) ;
for ( i =0; i<rw . l ength ; i++) {
try {
data [ rw [ i ] ] [ 9 ] = " Record : " ;
data [ rw [ i ] ] [ 1 0 ]= data [ rw [ i ] + 1 ] [ 0 ] ;
data [ rw [ i ] ] [ 1 1 ]= data [ rw [ i ] + 1 ] [ 1 ] ;
j=rw [ i ]+5;
sum=data [ j ] ;
j++;
while ( typeof ( data [ j ] [ 0 ] )=="number " & j<rw [ i +1]) {
for ( k=0;k<sum . l ength ; k++) sum [ k]+=data [ j ] [ k ] ;
j++;
}
rpt=bu i l d rp t (sum) ;
for ( k in rpt ) data [ rw [ i ] ] [ 1 2+Number(k ) ]= rpt [ k ] ;
s . getRange ( rw [ i ]+1 ,1 ,1 , data [ rw [ i ] ] . l ength ) . s e tVa lues ( [ data
[ rw [ i ] ] ] )
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s . getRange ( rw [ i ]+1 ,1 ,1 , data [ rw [ i ] ] . l ength ) .
setBackgroundColor ( "#99CC99" )
}
catch ( e ) {
rpt=bu i l d rp t (sum) ;
for ( k in rpt ) data [ rw [ i ] ] [ 1 2+Number(k ) ]= rpt [ k ] ;
s . getRange ( rw [ i ]+1 ,1 ,1 , data [ rw [ i ] ] . l ength ) . s e tVa lues ( [ data
[ rw [ i ] ] ] )
s . getRange ( rw [ i ]+1 ,1 ,1 , data [ rw [ i ] ] . l ength ) .
setBackgroundColor ( "#99CC99" )
break ;
}
}
c r e a t e ( )
}
function bu i l d rp t (sum) {
var out =[ ]
// o v e r a l l h i t v a l u e s
out . push (sum [ 2 ] / ( sum[2]+sum [ 5 ] ) ) ;
out . push (sum [ 3 ] / ( sum[3]+sum [ 6 ] ) ) ;
out . push (sum [ 4 ] / ( sum[4]+sum [ 7 ] ) ) ;
out . push (sum [ 8 ] / ( sum[8]+sum [ 9 ] ) ) ;
out . push (162−(sum[2]+sum[3]+sum[4]+sum[5]+sum[6]+sum[7]+sum
[8]+sum [ 9 ] ) ) ;
// o v e r a l l l a t va l u e s
out . push (sum [ 1 0 ] / ( sum[10]+sum [ 1 3 ] ) ) ; //h500 l a t
out . push (sum [ 1 1 ] / ( sum[11]+sum [ 1 4 ] ) ) ; //h100 l a t
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out . push (sum [ 1 2 ] / ( sum[12]+sum [ 1 5 ] ) ) ; //h25 l a t
out . push (sum [ 1 6 ] / ( sum[16]+sum [ 1 7 ] ) ) ; //CR l a t
return out ;
}
function c r e a t e ( ) {
var sheet1 = SpreadsheetApp . getAct iveSpreadsheet ( ) .
getSheetByName ( ’Raw ’ ) ;
var sheet2 = SpreadsheetApp . getAct iveSpreadsheet ( ) .
getSheetByName ( ’ Report ’ ) ;
var dest ;
var rowCount = 1 ;
var sheet1Length = sheet1 . getLastRow ( ) ;
var range1 = sheet1 . getRange (1 ,10 ) ;
var r ecL ine = range1 . getValue ( ) ;
for (var j = 1 ; j < sheet1Length ; j++){
range1 = sheet1 . getRange ( j , 1 0 ) ;
r ecL ine = range1 . getValue ( ) ;
i f ( r ecL ine == " Record : " ) {
var copyrange = sheet1 . getRange ( j , 1 1 , j , 1 8 ) ;
copyrange . copyValuesToRange ( sheet2 , 1 , 8 , rowCount+1,
rowCount+1) ;
rowCount++;
}
}
}
